AI has implications across the value chain in oncology, including in the diagnostics space, where agentic AI is making it easier to access and understand genomic data – an advance with applications in ...

Veeva delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ...

Pfizer has signed a strategic-level R&D alliance with Innovent Biologics, worth $10.5 billion and spanning a dozen programmes in oncology, in another sign of China's emergence as a life sciences R&D ...

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under a £340 million programme announced by the UK government. The initiative is part of the Pharmacy First ...

Bristol Myers Squibb has high hopes for its celmod programme for blood cancers, and a phase 3 readout – for mezigdomide in multiple myeloma – has delivered the goods. The cereblon E3 ligase modulator, ...

John Tsai is currently CEO of UK biotech Forcefield Therapeutics and a partner at investment group Syncona. Daiichi Sankyo has named John Tsai as its new global head of R&D, replacing Ken Takeshita, ...

Sudden unexpected death is a terrifying consequence faced by people living with uncontrolled tonic-clonic seizures (TCSs), so ...

As clinical research sites come under growing operational pressure, sponsors and CROs are being challenged to rethink how studies are designed and supported. Protocols are becoming more complex.

Sobi's $1.5 billion takeover of Arthrosi at the end of 2025 has started to pay off, with a positive phase 3 trial for gout ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, can achieve a functional cure in 19% of patients, ...

Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with ...